Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Boehringer Ingelheim
Healthtrust
Daiichi Sankyo
Merck
Fuji
McKesson
Teva
Accenture

Generated: August 21, 2018

DrugPatentWatch Database Preview

DEPO-TESTADIOL Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Summary for DEPO-TESTADIOL
Drug patent expirations by year for DEPO-TESTADIOL
Synonyms for DEPO-TESTADIOL
(17beta)-3-Oxoandrost-4-en-17-yl 3-cyclopentylpropanoate
(1S,2R,10R,11S,14S,15S)-2,15-DIMETHYL-5-OXOTETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADEC-6-EN-14-YL 3-CYCLOPENTYLPROPANOATE
(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl 3-cyclopentylpropanoate
[(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] 3-cyclopentylpropanoate
053T944
17-(3-cyclopentyl-1-propionyl)-17beta-hydroxyandrost-4-en-3-one
17-(Cyclopentyl-1-oxopropoxy)androst-4-en-3-one, (17.beta.)-
17.beta.-Hydroxyandrost-4-en-3-one cyclopentylpropionate
17beta-Hydroxyandrost-4-en-3-one cyclopentylpropionate
3-Oxoandrost-4-en-17-yl 3-cyclopentylpropanoate, (17.beta.)- #
3-oxoandrost-4-en-17beta-yl 3-cyclopentylpropanoate
58-20-8
AB0090519
AB01274709-01
AB2000228
AC1L9B3P
AKOS007930349
AKOS015895326
Andro-Cyp
Androst-4-en-3-one, 17-(3-cyclopentyl-1-oxopropoxy)-, (17.beta.)-
Androst-4-en-3-one, 17-(3-cyclopentyl-1-oxopropoxy)-, (17b)-
Androst-4-en-3-one, 17-(3-cyclopentyl-1-oxopropoxy)-, (17beta)-
BRN 3174363
C-21939
C08156
CC-34816
CHEBI:9463
CHEMBL1201101
CT0176
D00957
Dep-Test
depAndro 100
depAndro 200
Depo-Testosterone
Depo-testosterone (TN)
Depo-testosterone cyclopentylpropionate
Depo-Testosterone cypionate
Depovirin
Durandro
EINECS 200-368-4
HPFVBGJFAYZEBE-ZLQWOROUSA-N
Jectatest
LMST02020074
M0XW1UBI14
Malogen CYP
MolPort-003-959-637
NSC 9157
Pertestis
PL000354
SCHEMBL40862
T-Ionate-P.A
Testodrin prolongatum
Testosterone 17-beta-cypionate
Testosterone 17.beta.-cyclopentanepropionate
Testosterone 17.beta.-cyclopentylpropionate
Testosterone 17.beta.-cypionate
Testosterone 17beta-cyclopentanepropionate
Testosterone 17beta-cyclopentylpropionate
Testosterone 17beta-cypionate
Testosterone cyclopentanepropionate
Testosterone cyclopentylpropionate
TESTOSTERONE CYPIONATE
Testosterone cypionate (USP)
Testosterone cypionate [USP]
Testosterone cypionate, United States Pharmacopeia (USP) Reference Standard
Testosterone, cyclopentanepropionate
Testosteronecypionate
UNII-M0XW1UBI14
W-105407
ZINC4097468

US Patents and Regulatory Information for DEPO-TESTADIOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn DEPO-TESTADIOL estradiol cypionate; testosterone cypionate INJECTABLE;INJECTION 017968-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Deloitte
UBS
Johnson and Johnson
Harvard Business School
Cantor Fitzgerald
Colorcon
Daiichi Sankyo
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.